Gross Paul Edward
Officer at Clovis Oncology, Inc.
- Sold, on record
- $425k
- Dollars the filings state
- Form 4 sales
- 27
- Latest Nov 2, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Clovis Oncology, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Clovis Oncology, Inc.Plan not statedDec 2, 2021 2021
Sold 248 shares at $3.00 ($744)
Gross Paul Edward, Officer
Sold 0.4% of holdings ($185k position)61,357 shares left0.2x usual sizeFiling
- 2 Form 4 sale Clovis Oncology, Inc.UnusualFeb 2, 2022 +62 days
Sold 5,436 shares at $1.94 ($11k)
Gross Paul Edward, Officer
Sold 7.6% of holdings ($139k position)66,171 shares left4x usual sizeFiling
- 3 Form 4 sale Clovis Oncology, Inc.UnusualMar 2, 2022 +28 days
Sold 10,706 shares at $1.87 ($20k)
Gross Paul Edward, Officer
Sold 12.3% of holdings ($163k position)76,278 shares left8x usual sizeFiling
- 4 Form 4 sale Clovis Oncology, Inc.Plan not statedMay 2, 2022 +61 days
Sold 4,570 shares at $1.97 ($9k)
Gross Paul Edward, Officer
Sold 5.3% of holdings ($170k position)81,956 shares left1.9x usual sizeFiling
- 5 Form 4 sale Clovis Oncology, Inc.Plan not statedJun 2, 2022 +31 days
Sold 2,403 shares at $0.64 ($2k)
Gross Paul Edward, Officer
Sold 2.8% of holdings ($56k position)84,615 shares left1x usual sizeFiling
- 6 Form 4 sale Clovis Oncology, Inc.Plan not statedAug 2, 2022 +61 days
Sold 4,807 shares at $1.46 ($7k)
Gross Paul Edward, Officer
Sold 5.1% of holdings ($139k position)90,057 shares left1.9x usual sizeFiling
- 7 Form 4 sale Clovis Oncology, Inc.Plan not statedSep 2, 2022 +31 days
Sold 2,308 shares at $1.20 ($3k)
Gross Paul Edward, Officer
Sold 2.4% of holdings ($114k position)92,812 shares left0.5x usual sizeFiling
- 8 Form 4 sale Clovis Oncology, Inc.Plan not statedNov 2, 2022 +61 days
Sold 4,730 shares at $0.98 ($5k)
Gross Paul Edward, Officer
Sold 4.6% of holdings ($101k position)98,330 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (27)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2022 | Nov 3, 2022 | Clovis Oncology, Inc. | Officer | Form 4 sale | 4,730 | $5k | 4.6% | Plan not stated | SEC |
| Sep 2, 2022 | Sep 6, 2022 | Clovis Oncology, Inc. | Officer | Form 4 sale | 2,308 | $3k | 2.4% | Plan not stated | SEC |
| Aug 2, 2022 | Aug 3, 2022 | Clovis Oncology, Inc. | Officer | Form 4 sale | 4,807 | $7k | 5.1% | Plan not stated | SEC |
| Jun 2, 2022 | Jun 3, 2022 | Clovis Oncology, Inc. | Officer | Form 4 sale | 2,403 | $2k | 2.8% | Plan not stated | SEC |
| May 2, 2022 | May 3, 2022 | Clovis Oncology, Inc. | Officer | Form 4 sale | 4,570 | $9k | 5.3% | Plan not stated | SEC |
| Mar 2, 2022 | Mar 3, 2022 | Clovis Oncology, Inc. | Officer | Form 4 sale | 10,706 | $20k | 12.3% | Unusual | SEC |
| Feb 2, 2022 | Feb 3, 2022 | Clovis Oncology, Inc. | Officer | Form 4 sale | 5,436 | $11k | 7.6% | Unusual | SEC |
| Dec 2, 2021 | Dec 3, 2021 | Clovis Oncology, Inc. | Officer | Form 4 sale | 248 | $744 | 0.4% | Plan not stated | SEC |
| Nov 2, 2021 | Nov 3, 2021 | Clovis Oncology, Inc. | Officer | Form 4 sale | 4,523 | $21k | 6.9% | Unusual | SEC |
| Sep 2, 2021 | Sep 3, 2021 | Clovis Oncology, Inc. | Officer | Form 4 sale | 249 | $1k | 0.4% | Plan not stated | SEC |
| Aug 3, 2021 | Aug 3, 2021 | Clovis Oncology, Inc. | Officer | Form 4 sale | 4,507 | $22k | 7.6% | Unusual | SEC |
| Jun 3, 2021 | Jun 3, 2021 | Clovis Oncology, Inc. | Officer | Form 4 sale | 231 | $1k | 0.5% | Plan not stated | SEC |
| May 4, 2021 | May 4, 2021 | Clovis Oncology, Inc. | Officer | Form 4 sale | 4,838 | $27k | 9.0% | Unusual | SEC |
| Mar 2, 2021 | Mar 3, 2021 | Clovis Oncology, Inc. | Officer | Form 4 sale | 456 | $3k | 1.0% | Plan not stated | SEC |
| Feb 2, 2021 | Feb 3, 2021 | Clovis Oncology, Inc. | Officer | Form 4 sale | 11,873 | $95k | 21.7% | Unusual | SEC |
| Dec 3, 2020 | Dec 7, 2020 | Clovis Oncology, Inc. | Officer | Form 4 sale | 457 | $2k | 1.5% | Plan not stated | SEC |
| Nov 3, 2020 | Nov 5, 2020 | Clovis Oncology, Inc. | Officer | Form 4 sale | 2,534 | $12k | 7.8% | Unusual | SEC |
| Sep 3, 2020 | Sep 8, 2020 | Clovis Oncology, Inc. | Officer | Form 4 sale | 435 | $2k | 1.6% | Plan not stated | SEC |
| Aug 3, 2020 | Aug 5, 2020 | Clovis Oncology, Inc. | Officer | Form 4 sale | 2,506 | $15k | 8.7% | Unusual | SEC |
| Jun 3, 2020 | Jun 5, 2020 | Clovis Oncology, Inc. | Officer | Form 4 sale | 470 | $3k | 2.0% | Plan not stated | SEC |
| May 5, 2020 | May 7, 2020 | Clovis Oncology, Inc. | Officer | Form 4 sale | 2,213 | $18k | 8.9% | Unusual | SEC |
| Mar 3, 2020 | Mar 5, 2020 | Clovis Oncology, Inc. | Officer | Form 4 sale | 475 | $3k | 2.4% | Plan not stated | SEC |
| Feb 4, 2020 | Feb 6, 2020 | Clovis Oncology, Inc. | Officer | Form 4 sale | 10,470 | $88k | 35.8% | Unusual | SEC |
| Dec 3, 2019 | Dec 5, 2019 | Clovis Oncology, Inc. | Officer | Form 4 sale | 466 | $7k | 6.7% | Plan not stated | SEC |
| Sep 4, 2019 | Sep 6, 2019 | Clovis Oncology, Inc. | Officer | Form 4 sale | 495 | $3k | 7.7% | Plan not stated | SEC |
| Jun 4, 2019 | Jun 6, 2019 | Clovis Oncology, Inc. | Officer | Form 4 sale | 453 | $7k | 9.5% | Plan not stated | SEC |
| Mar 5, 2019 | Mar 6, 2019 | Clovis Oncology, Inc. | Officer | Form 4 sale | 1,325 | $39k | 26.2% | Unusual | SEC |